Arcturus Therapeutics Holdings Inc (ARCT)
27.07
-0.47
(-1.71%)
USD |
NASDAQ |
May 08, 10:38
Arcturus Therapeutics Holdings Price to Book Value: 2.617 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 2.663 |
| May 06, 2024 | 2.641 |
| May 03, 2024 | 2.637 |
| May 02, 2024 | 2.564 |
| May 01, 2024 | 2.698 |
| April 30, 2024 | 2.472 |
| April 29, 2024 | 2.575 |
| April 26, 2024 | 2.567 |
| April 25, 2024 | 2.530 |
| April 24, 2024 | 2.609 |
| April 23, 2024 | 2.700 |
| April 22, 2024 | 2.616 |
| April 19, 2024 | 2.511 |
| April 18, 2024 | 2.544 |
| April 17, 2024 | 2.672 |
| April 16, 2024 | 2.912 |
| April 15, 2024 | 2.833 |
| April 12, 2024 | 2.941 |
| April 11, 2024 | 3.145 |
| April 10, 2024 | 3.077 |
| April 09, 2024 | 3.060 |
| April 08, 2024 | 2.989 |
| April 05, 2024 | 3.090 |
| April 04, 2024 | 2.957 |
| April 03, 2024 | 3.164 |
| Date | Value |
|---|---|
| April 02, 2024 | 3.114 |
| April 01, 2024 | 3.197 |
| March 28, 2024 | 3.264 |
| March 27, 2024 | 3.176 |
| March 26, 2024 | 3.105 |
| March 25, 2024 | 3.362 |
| March 22, 2024 | 3.276 |
| March 21, 2024 | 3.202 |
| March 20, 2024 | 3.204 |
| March 19, 2024 | 3.262 |
| March 18, 2024 | 3.202 |
| March 15, 2024 | 3.509 |
| March 14, 2024 | 3.515 |
| March 13, 2024 | 3.663 |
| March 12, 2024 | 3.739 |
| March 11, 2024 | 3.662 |
| March 08, 2024 | 3.562 |
| March 07, 2024 | 3.594 |
| March 06, 2024 | 3.651 |
| March 05, 2024 | 3.630 |
| March 04, 2024 | 3.638 |
| March 01, 2024 | 3.827 |
| February 29, 2024 | 3.734 |
| February 28, 2024 | 3.870 |
| February 27, 2024 | 4.141 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.446
Minimum
Mar 22 2023
70.31
Maximum
May 22 2020
6.222
Average
3.381
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.308 |
| Perspective Therapeutics Inc | 14.21 |
| Protalix BioTherapeutics Inc | 2.437 |
| Electromed Inc | 3.835 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 4.596 |
| Price | 27.07 |
| Earnings Yield | -3.84% |
| Market Cap | 728.94M |